first reported that a patient with advanced NSCLC, who was initially diagnosed with poorly differentiated carcinoma and without EGFR gene mutation, experienced histological transformation into SCLC after immunotherapy resistance to nivolumab (6). This evidence concerns the gene EGFR and small cell lung carcinoma.